Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1982-02-19
1983-05-31
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 3113
Patent
active
043861059
ABSTRACT:
Warm-blooded animals are treated by administering to the animal a dosage, effective to alleviate the symptoms of measles, of a compound of the formula I or its acid salt: ##STR1## wherein R.sub.1 and R.sub.2 are selected from the class consisting of hydrogen and --CH.sub.3 and at least on pharmaceutically acceptable carrier, wherein the compound is 0.01 to 95% by weight of the composition.
REFERENCES:
patent: 3592934 (1971-07-01), Prichard
Griffith Ronald C.
Kinsolving Clyde R.
Goldberg Jerome D.
Pennwalt Corporation
LandOfFree
Use of alpha, alpha-dialkyl adamantylethylamines to treat measle does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of alpha, alpha-dialkyl adamantylethylamines to treat measle, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of alpha, alpha-dialkyl adamantylethylamines to treat measle will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2245900